IGHE and asthma: The more ubiquitous mechanism of action of dupilumab also allows it to interact, albeit indirectly, with the action of IgE and, thus, on some of those mechanisms that may be most characteristic of patients with an allergic form of asthma, allowing clinicians to consider it for this type of patient as well as for their therapy [83].